nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ABCB1—Progesterone—uterine cancer	0.106	0.175	CbGbCtD
Mirabegron—CYP2D6—Progesterone—uterine cancer	0.1	0.164	CbGbCtD
Mirabegron—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0963	0.158	CbGbCtD
Mirabegron—ABCB1—Dactinomycin—uterine cancer	0.0844	0.138	CbGbCtD
Mirabegron—CYP3A4—Progesterone—uterine cancer	0.0638	0.105	CbGbCtD
Mirabegron—ABCB1—Etoposide—uterine cancer	0.0476	0.0781	CbGbCtD
Mirabegron—ABCB1—Doxorubicin—uterine cancer	0.0325	0.0533	CbGbCtD
Mirabegron—CYP2D6—Doxorubicin—uterine cancer	0.0306	0.0502	CbGbCtD
Mirabegron—CYP3A4—Etoposide—uterine cancer	0.0285	0.0468	CbGbCtD
Mirabegron—CYP3A4—Doxorubicin—uterine cancer	0.0195	0.0319	CbGbCtD
Mirabegron—Rash papular—Epirubicin—uterine cancer	0.00306	0.00814	CcSEcCtD
Mirabegron—Purpura—Progesterone—uterine cancer	0.003	0.00796	CcSEcCtD
Mirabegron—Osteoarthritis—Progesterone—uterine cancer	0.00289	0.00768	CcSEcCtD
Mirabegron—Rash papular—Doxorubicin—uterine cancer	0.00284	0.00753	CcSEcCtD
Mirabegron—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.00722	CcSEcCtD
Mirabegron—Infection—Carboplatin—uterine cancer	0.00269	0.00713	CcSEcCtD
Mirabegron—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.0071	CcSEcCtD
Mirabegron—Osteoarthritis—Medroxyprogesterone Acetate—uterine cancer	0.00262	0.00696	CcSEcCtD
Mirabegron—Breast disorder—Progesterone—uterine cancer	0.00261	0.00694	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.0026	0.00691	CcSEcCtD
Mirabegron—Nasopharyngitis—Progesterone—uterine cancer	0.00258	0.00686	CcSEcCtD
Mirabegron—Gastritis—Progesterone—uterine cancer	0.00256	0.00679	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00255	0.00677	CcSEcCtD
Mirabegron—Abdominal distension—Progesterone—uterine cancer	0.00251	0.00668	CcSEcCtD
Mirabegron—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00249	0.00661	CcSEcCtD
Mirabegron—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00629	CcSEcCtD
Mirabegron—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00622	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Progesterone—uterine cancer	0.00232	0.00617	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.00613	CcSEcCtD
Mirabegron—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00605	CcSEcCtD
Mirabegron—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00601	CcSEcCtD
Mirabegron—Lactic dehydrogenase activity increased—Epirubicin—uterine cancer	0.00223	0.00593	CcSEcCtD
Mirabegron—Infestation NOS—Progesterone—uterine cancer	0.00223	0.00591	CcSEcCtD
Mirabegron—Infestation—Progesterone—uterine cancer	0.00223	0.00591	CcSEcCtD
Mirabegron—Urinary tract infection—Progesterone—uterine cancer	0.00216	0.00575	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00559	CcSEcCtD
Mirabegron—Sinusitis—Progesterone—uterine cancer	0.00209	0.00555	CcSEcCtD
Mirabegron—Lactic dehydrogenase activity increased—Doxorubicin—uterine cancer	0.00206	0.00548	CcSEcCtD
Mirabegron—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00536	CcSEcCtD
Mirabegron—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00536	CcSEcCtD
Mirabegron—Rhinitis—Progesterone—uterine cancer	0.002	0.00532	CcSEcCtD
Mirabegron—Urinary tract disorder—Progesterone—uterine cancer	0.00197	0.00524	CcSEcCtD
Mirabegron—Connective tissue disorder—Progesterone—uterine cancer	0.00196	0.00522	CcSEcCtD
Mirabegron—Blood lactate dehydrogenase increased—Epirubicin—uterine cancer	0.00196	0.00522	CcSEcCtD
Mirabegron—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00521	CcSEcCtD
Mirabegron—Urethral disorder—Progesterone—uterine cancer	0.00196	0.00521	CcSEcCtD
Mirabegron—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00503	CcSEcCtD
Mirabegron—Erythema multiforme—Progesterone—uterine cancer	0.00189	0.00502	CcSEcCtD
Mirabegron—Eye disorder—Progesterone—uterine cancer	0.00187	0.00496	CcSEcCtD
Mirabegron—Cardiac disorder—Progesterone—uterine cancer	0.00186	0.00493	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00184	0.00489	CcSEcCtD
Mirabegron—Blood lactate dehydrogenase increased—Doxorubicin—uterine cancer	0.00182	0.00483	CcSEcCtD
Mirabegron—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00475	CcSEcCtD
Mirabegron—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00473	CcSEcCtD
Mirabegron—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00472	CcSEcCtD
Mirabegron—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00455	CcSEcCtD
Mirabegron—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.0045	CcSEcCtD
Mirabegron—Back pain—Progesterone—uterine cancer	0.00168	0.00447	CcSEcCtD
Mirabegron—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00447	CcSEcCtD
Mirabegron—Vision blurred—Progesterone—uterine cancer	0.00164	0.00436	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00156	0.00414	CcSEcCtD
Mirabegron—Palpitations—Progesterone—uterine cancer	0.00154	0.00408	CcSEcCtD
Mirabegron—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00405	CcSEcCtD
Mirabegron—Hypertension—Progesterone—uterine cancer	0.0015	0.00399	CcSEcCtD
Mirabegron—Arthralgia—Progesterone—uterine cancer	0.00148	0.00394	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00147	0.00391	CcSEcCtD
Mirabegron—Dry mouth—Progesterone—uterine cancer	0.00145	0.00385	CcSEcCtD
Mirabegron—Infection—Progesterone—uterine cancer	0.00141	0.00375	CcSEcCtD
Mirabegron—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.0037	CcSEcCtD
Mirabegron—Tachycardia—Progesterone—uterine cancer	0.00139	0.00368	CcSEcCtD
Mirabegron—Skin disorder—Progesterone—uterine cancer	0.00138	0.00366	CcSEcCtD
Mirabegron—ADRB3—female reproductive system—uterine cancer	0.00137	0.102	CbGeAlD
Mirabegron—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00357	CcSEcCtD
Mirabegron—Erythema multiforme—Dactinomycin—uterine cancer	0.00134	0.00355	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00354	CcSEcCtD
Mirabegron—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00349	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Etoposide—uterine cancer	0.0013	0.00346	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00129	0.00344	CcSEcCtD
Mirabegron—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0034	CcSEcCtD
Mirabegron—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00334	CcSEcCtD
Mirabegron—Dyspepsia—Progesterone—uterine cancer	0.00125	0.00332	CcSEcCtD
Mirabegron—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00332	CcSEcCtD
Mirabegron—ADRB3—female gonad—uterine cancer	0.00125	0.0924	CbGeAlD
Mirabegron—Gastrointestinal disorder—Progesterone—uterine cancer	0.00123	0.00326	CcSEcCtD
Mirabegron—Fatigue—Progesterone—uterine cancer	0.00122	0.00325	CcSEcCtD
Mirabegron—Constipation—Progesterone—uterine cancer	0.00121	0.00323	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00311	CcSEcCtD
Mirabegron—Gastrointestinal pain—Progesterone—uterine cancer	0.00116	0.00308	CcSEcCtD
Mirabegron—Infestation—Etoposide—uterine cancer	0.00114	0.00303	CcSEcCtD
Mirabegron—Infestation NOS—Etoposide—uterine cancer	0.00114	0.00303	CcSEcCtD
Mirabegron—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00301	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00113	0.003	CcSEcCtD
Mirabegron—Urticaria—Progesterone—uterine cancer	0.00113	0.003	CcSEcCtD
Mirabegron—Abdominal pain—Progesterone—uterine cancer	0.00112	0.00298	CcSEcCtD
Mirabegron—Cystitis noninfective—Epirubicin—uterine cancer	0.00111	0.00296	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00295	CcSEcCtD
Mirabegron—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00295	CcSEcCtD
Mirabegron—Cystitis—Epirubicin—uterine cancer	0.0011	0.00293	CcSEcCtD
Mirabegron—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00292	CcSEcCtD
Mirabegron—Vaginal infection—Epirubicin—uterine cancer	0.00108	0.00286	CcSEcCtD
Mirabegron—Dry eye—Epirubicin—uterine cancer	0.00105	0.0028	CcSEcCtD
Mirabegron—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.0028	CcSEcCtD
Mirabegron—Bladder pain—Epirubicin—uterine cancer	0.00103	0.00274	CcSEcCtD
Mirabegron—Neoplasm—Epirubicin—uterine cancer	0.00103	0.00274	CcSEcCtD
Mirabegron—Cystitis noninfective—Doxorubicin—uterine cancer	0.00103	0.00274	CcSEcCtD
Mirabegron—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00272	CcSEcCtD
Mirabegron—Cystitis—Doxorubicin—uterine cancer	0.00102	0.00271	CcSEcCtD
Mirabegron—Asthenia—Progesterone—uterine cancer	0.00102	0.00271	CcSEcCtD
Mirabegron—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0027	CcSEcCtD
Mirabegron—Urinary tract disorder—Etoposide—uterine cancer	0.00101	0.00268	CcSEcCtD
Mirabegron—Pruritus—Progesterone—uterine cancer	0.001	0.00267	CcSEcCtD
Mirabegron—Urethral disorder—Etoposide—uterine cancer	0.001	0.00266	CcSEcCtD
Mirabegron—Infection—Dactinomycin—uterine cancer	0.000997	0.00265	CcSEcCtD
Mirabegron—Vaginal infection—Doxorubicin—uterine cancer	0.000997	0.00265	CcSEcCtD
Mirabegron—Dry eye—Doxorubicin—uterine cancer	0.000975	0.00259	CcSEcCtD
Mirabegron—Diarrhoea—Progesterone—uterine cancer	0.000972	0.00258	CcSEcCtD
Mirabegron—Erythema multiforme—Etoposide—uterine cancer	0.000967	0.00257	CcSEcCtD
Mirabegron—Eye disorder—Etoposide—uterine cancer	0.000956	0.00254	CcSEcCtD
Mirabegron—Bladder pain—Doxorubicin—uterine cancer	0.000955	0.00254	CcSEcCtD
Mirabegron—Neoplasm—Doxorubicin—uterine cancer	0.000955	0.00254	CcSEcCtD
Mirabegron—Cardiac disorder—Etoposide—uterine cancer	0.000949	0.00252	CcSEcCtD
Mirabegron—Dizziness—Progesterone—uterine cancer	0.000939	0.00249	CcSEcCtD
Mirabegron—Vascular purpura—Epirubicin—uterine cancer	0.000926	0.00246	CcSEcCtD
Mirabegron—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000923	0.00245	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000914	0.00243	CcSEcCtD
Mirabegron—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00091	0.00242	CcSEcCtD
Mirabegron—Rash—Progesterone—uterine cancer	0.000895	0.00238	CcSEcCtD
Mirabegron—Dermatitis—Progesterone—uterine cancer	0.000895	0.00238	CcSEcCtD
Mirabegron—Headache—Progesterone—uterine cancer	0.00089	0.00236	CcSEcCtD
Mirabegron—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00088	0.00234	CcSEcCtD
Mirabegron—Fatigue—Dactinomycin—uterine cancer	0.000865	0.0023	CcSEcCtD
Mirabegron—Back pain—Etoposide—uterine cancer	0.000861	0.00229	CcSEcCtD
Mirabegron—Purpura—Epirubicin—uterine cancer	0.00086	0.00228	CcSEcCtD
Mirabegron—Vascular purpura—Doxorubicin—uterine cancer	0.000857	0.00228	CcSEcCtD
Mirabegron—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000851	0.00226	CcSEcCtD
Mirabegron—Cerebrovascular accident—Epirubicin—uterine cancer	0.000845	0.00225	CcSEcCtD
Mirabegron—Nausea—Progesterone—uterine cancer	0.000844	0.00224	CcSEcCtD
Mirabegron—Osteoarthritis—Epirubicin—uterine cancer	0.000829	0.0022	CcSEcCtD
Mirabegron—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000821	0.00218	CcSEcCtD
Mirabegron—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000811	0.00216	CcSEcCtD
Mirabegron—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000811	0.00215	CcSEcCtD
Mirabegron—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000806	0.00214	CcSEcCtD
Mirabegron—Purpura—Doxorubicin—uterine cancer	0.000795	0.00211	CcSEcCtD
Mirabegron—Abdominal pain—Dactinomycin—uterine cancer	0.000793	0.00211	CcSEcCtD
Mirabegron—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000782	0.00208	CcSEcCtD
Mirabegron—ORM1—endometrium—uterine cancer	0.000769	0.0568	CbGeAlD
Mirabegron—Hypertension—Etoposide—uterine cancer	0.000769	0.00204	CcSEcCtD
Mirabegron—Osteoarthritis—Doxorubicin—uterine cancer	0.000767	0.00204	CcSEcCtD
Mirabegron—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000764	0.00203	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000753	0.002	CcSEcCtD
Mirabegron—Breast disorder—Epirubicin—uterine cancer	0.000749	0.00199	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000746	0.00198	CcSEcCtD
Mirabegron—Nasopharyngitis—Epirubicin—uterine cancer	0.000741	0.00197	CcSEcCtD
Mirabegron—Gastritis—Epirubicin—uterine cancer	0.000733	0.00195	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000731	0.00194	CcSEcCtD
Mirabegron—Infection—Etoposide—uterine cancer	0.000722	0.00192	CcSEcCtD
Mirabegron—Abdominal distension—Epirubicin—uterine cancer	0.000721	0.00192	CcSEcCtD
Mirabegron—Asthenia—Dactinomycin—uterine cancer	0.00072	0.00191	CcSEcCtD
Mirabegron—Influenza—Epirubicin—uterine cancer	0.000716	0.0019	CcSEcCtD
Mirabegron—Tachycardia—Etoposide—uterine cancer	0.000709	0.00188	CcSEcCtD
Mirabegron—Skin disorder—Etoposide—uterine cancer	0.000706	0.00187	CcSEcCtD
Mirabegron—SLCO1A2—renal system—uterine cancer	0.000701	0.0519	CbGeAlD
Mirabegron—Breast disorder—Doxorubicin—uterine cancer	0.000693	0.00184	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00069	0.00183	CcSEcCtD
Mirabegron—Diarrhoea—Dactinomycin—uterine cancer	0.000687	0.00182	CcSEcCtD
Mirabegron—Nasopharyngitis—Doxorubicin—uterine cancer	0.000686	0.00182	CcSEcCtD
Mirabegron—Gastritis—Doxorubicin—uterine cancer	0.000678	0.0018	CcSEcCtD
Mirabegron—BCHE—myometrium—uterine cancer	0.000677	0.0501	CbGeAlD
Mirabegron—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000676	0.0018	CcSEcCtD
Mirabegron—Abdominal distension—Doxorubicin—uterine cancer	0.000667	0.00177	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000666	0.00177	CcSEcCtD
Mirabegron—Influenza—Doxorubicin—uterine cancer	0.000663	0.00176	CcSEcCtD
Mirabegron—Infestation—Epirubicin—uterine cancer	0.000638	0.0017	CcSEcCtD
Mirabegron—Infestation NOS—Epirubicin—uterine cancer	0.000638	0.0017	CcSEcCtD
Mirabegron—ORM1—female reproductive system—uterine cancer	0.000637	0.0471	CbGeAlD
Mirabegron—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000633	0.00168	CcSEcCtD
Mirabegron—Rash—Dactinomycin—uterine cancer	0.000633	0.00168	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Etoposide—uterine cancer	0.000627	0.00167	CcSEcCtD
Mirabegron—Fatigue—Etoposide—uterine cancer	0.000626	0.00166	CcSEcCtD
Mirabegron—Constipation—Etoposide—uterine cancer	0.000621	0.00165	CcSEcCtD
Mirabegron—Urinary tract infection—Epirubicin—uterine cancer	0.000621	0.00165	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000616	0.00164	CcSEcCtD
Mirabegron—Sinusitis—Epirubicin—uterine cancer	0.000599	0.00159	CcSEcCtD
Mirabegron—Nausea—Dactinomycin—uterine cancer	0.000596	0.00158	CcSEcCtD
Mirabegron—Gastrointestinal pain—Etoposide—uterine cancer	0.000594	0.00158	CcSEcCtD
Mirabegron—Infestation NOS—Doxorubicin—uterine cancer	0.000591	0.00157	CcSEcCtD
Mirabegron—Infestation—Doxorubicin—uterine cancer	0.000591	0.00157	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000586	0.00156	CcSEcCtD
Mirabegron—Urticaria—Etoposide—uterine cancer	0.000577	0.00153	CcSEcCtD
Mirabegron—Rhinitis—Epirubicin—uterine cancer	0.000575	0.00153	CcSEcCtD
Mirabegron—Abdominal pain—Etoposide—uterine cancer	0.000574	0.00153	CcSEcCtD
Mirabegron—Urinary tract infection—Doxorubicin—uterine cancer	0.000574	0.00153	CcSEcCtD
Mirabegron—Urinary tract disorder—Epirubicin—uterine cancer	0.000566	0.0015	CcSEcCtD
Mirabegron—Connective tissue disorder—Epirubicin—uterine cancer	0.000563	0.0015	CcSEcCtD
Mirabegron—Urethral disorder—Epirubicin—uterine cancer	0.000562	0.00149	CcSEcCtD
Mirabegron—Sinusitis—Doxorubicin—uterine cancer	0.000554	0.00147	CcSEcCtD
Mirabegron—Erythema multiforme—Epirubicin—uterine cancer	0.000542	0.00144	CcSEcCtD
Mirabegron—Eye disorder—Epirubicin—uterine cancer	0.000536	0.00142	CcSEcCtD
Mirabegron—Cardiac disorder—Epirubicin—uterine cancer	0.000532	0.00141	CcSEcCtD
Mirabegron—Rhinitis—Doxorubicin—uterine cancer	0.000532	0.00141	CcSEcCtD
Mirabegron—BCHE—uterine cervix—uterine cancer	0.000527	0.039	CbGeAlD
Mirabegron—Urinary tract disorder—Doxorubicin—uterine cancer	0.000524	0.00139	CcSEcCtD
Mirabegron—Asthenia—Etoposide—uterine cancer	0.000521	0.00138	CcSEcCtD
Mirabegron—Connective tissue disorder—Doxorubicin—uterine cancer	0.000521	0.00138	CcSEcCtD
Mirabegron—Urethral disorder—Doxorubicin—uterine cancer	0.00052	0.00138	CcSEcCtD
Mirabegron—Pruritus—Etoposide—uterine cancer	0.000514	0.00137	CcSEcCtD
Mirabegron—BCHE—smooth muscle tissue—uterine cancer	0.000512	0.0379	CbGeAlD
Mirabegron—Erythema multiforme—Doxorubicin—uterine cancer	0.000501	0.00133	CcSEcCtD
Mirabegron—Diarrhoea—Etoposide—uterine cancer	0.000497	0.00132	CcSEcCtD
Mirabegron—Eye disorder—Doxorubicin—uterine cancer	0.000496	0.00132	CcSEcCtD
Mirabegron—Cardiac disorder—Doxorubicin—uterine cancer	0.000492	0.00131	CcSEcCtD
Mirabegron—Back pain—Epirubicin—uterine cancer	0.000483	0.00128	CcSEcCtD
Mirabegron—Dizziness—Etoposide—uterine cancer	0.00048	0.00128	CcSEcCtD
Mirabegron—BCHE—endometrium—uterine cancer	0.000477	0.0352	CbGeAlD
Mirabegron—Vision blurred—Epirubicin—uterine cancer	0.00047	0.00125	CcSEcCtD
Mirabegron—BCHE—mammalian vulva—uterine cancer	0.000461	0.0341	CbGeAlD
Mirabegron—Rash—Etoposide—uterine cancer	0.000458	0.00122	CcSEcCtD
Mirabegron—Dermatitis—Etoposide—uterine cancer	0.000458	0.00122	CcSEcCtD
Mirabegron—Headache—Etoposide—uterine cancer	0.000455	0.00121	CcSEcCtD
Mirabegron—Back pain—Doxorubicin—uterine cancer	0.000447	0.00119	CcSEcCtD
Mirabegron—Palpitations—Epirubicin—uterine cancer	0.000441	0.00117	CcSEcCtD
Mirabegron—BCHE—uterus—uterine cancer	0.000439	0.0325	CbGeAlD
Mirabegron—Vision blurred—Doxorubicin—uterine cancer	0.000435	0.00116	CcSEcCtD
Mirabegron—Nausea—Etoposide—uterine cancer	0.000432	0.00115	CcSEcCtD
Mirabegron—Hypertension—Epirubicin—uterine cancer	0.000431	0.00114	CcSEcCtD
Mirabegron—Arthralgia—Epirubicin—uterine cancer	0.000425	0.00113	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000422	0.00112	CcSEcCtD
Mirabegron—Dry mouth—Epirubicin—uterine cancer	0.000415	0.0011	CcSEcCtD
Mirabegron—Palpitations—Doxorubicin—uterine cancer	0.000408	0.00108	CcSEcCtD
Mirabegron—Infection—Epirubicin—uterine cancer	0.000405	0.00107	CcSEcCtD
Mirabegron—Hypertension—Doxorubicin—uterine cancer	0.000399	0.00106	CcSEcCtD
Mirabegron—Tachycardia—Epirubicin—uterine cancer	0.000397	0.00106	CcSEcCtD
Mirabegron—Skin disorder—Epirubicin—uterine cancer	0.000396	0.00105	CcSEcCtD
Mirabegron—BCHE—female reproductive system—uterine cancer	0.000395	0.0292	CbGeAlD
Mirabegron—Arthralgia—Doxorubicin—uterine cancer	0.000393	0.00104	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00039	0.00104	CcSEcCtD
Mirabegron—Dry mouth—Doxorubicin—uterine cancer	0.000384	0.00102	CcSEcCtD
Mirabegron—Infection—Doxorubicin—uterine cancer	0.000374	0.000994	CcSEcCtD
Mirabegron—ORM1—lymph node—uterine cancer	0.000373	0.0275	CbGeAlD
Mirabegron—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000371	0.000986	CcSEcCtD
Mirabegron—Tachycardia—Doxorubicin—uterine cancer	0.000368	0.000977	CcSEcCtD
Mirabegron—Skin disorder—Doxorubicin—uterine cancer	0.000366	0.000972	CcSEcCtD
Mirabegron—Dyspepsia—Epirubicin—uterine cancer	0.000358	0.000952	CcSEcCtD
Mirabegron—BCHE—vagina—uterine cancer	0.000357	0.0264	CbGeAlD
Mirabegron—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000352	0.000934	CcSEcCtD
Mirabegron—Fatigue—Epirubicin—uterine cancer	0.000351	0.000933	CcSEcCtD
Mirabegron—Constipation—Epirubicin—uterine cancer	0.000348	0.000925	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000343	0.000912	CcSEcCtD
Mirabegron—Gastrointestinal pain—Epirubicin—uterine cancer	0.000333	0.000885	CcSEcCtD
Mirabegron—CYP3A4—renal system—uterine cancer	0.000332	0.0245	CbGeAlD
Mirabegron—Dyspepsia—Doxorubicin—uterine cancer	0.000332	0.000881	CcSEcCtD
Mirabegron—ALB—lymph node—uterine cancer	0.000327	0.0242	CbGeAlD
Mirabegron—CYP2D6—renal system—uterine cancer	0.000327	0.0241	CbGeAlD
Mirabegron—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000325	0.000864	CcSEcCtD
Mirabegron—Fatigue—Doxorubicin—uterine cancer	0.000325	0.000863	CcSEcCtD
Mirabegron—Urticaria—Epirubicin—uterine cancer	0.000324	0.000859	CcSEcCtD
Mirabegron—ABCB1—myometrium—uterine cancer	0.000323	0.0239	CbGeAlD
Mirabegron—Constipation—Doxorubicin—uterine cancer	0.000322	0.000856	CcSEcCtD
Mirabegron—Abdominal pain—Epirubicin—uterine cancer	0.000322	0.000855	CcSEcCtD
Mirabegron—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000308	0.000818	CcSEcCtD
Mirabegron—Urticaria—Doxorubicin—uterine cancer	0.000299	0.000795	CcSEcCtD
Mirabegron—Abdominal pain—Doxorubicin—uterine cancer	0.000298	0.000791	CcSEcCtD
Mirabegron—Asthenia—Epirubicin—uterine cancer	0.000292	0.000776	CcSEcCtD
Mirabegron—Pruritus—Epirubicin—uterine cancer	0.000288	0.000765	CcSEcCtD
Mirabegron—Diarrhoea—Epirubicin—uterine cancer	0.000279	0.00074	CcSEcCtD
Mirabegron—Asthenia—Doxorubicin—uterine cancer	0.00027	0.000718	CcSEcCtD
Mirabegron—Dizziness—Epirubicin—uterine cancer	0.000269	0.000715	CcSEcCtD
Mirabegron—Pruritus—Doxorubicin—uterine cancer	0.000267	0.000708	CcSEcCtD
Mirabegron—CYP3A4—female reproductive system—uterine cancer	0.000266	0.0197	CbGeAlD
Mirabegron—CYP2D6—female reproductive system—uterine cancer	0.000262	0.0193	CbGeAlD
Mirabegron—Diarrhoea—Doxorubicin—uterine cancer	0.000258	0.000685	CcSEcCtD
Mirabegron—Rash—Epirubicin—uterine cancer	0.000257	0.000682	CcSEcCtD
Mirabegron—Dermatitis—Epirubicin—uterine cancer	0.000257	0.000681	CcSEcCtD
Mirabegron—Headache—Epirubicin—uterine cancer	0.000255	0.000678	CcSEcCtD
Mirabegron—ABCB1—epithelium—uterine cancer	0.000253	0.0187	CbGeAlD
Mirabegron—ABCB1—uterine cervix—uterine cancer	0.000251	0.0186	CbGeAlD
Mirabegron—Dizziness—Doxorubicin—uterine cancer	0.000249	0.000662	CcSEcCtD
Mirabegron—Nausea—Epirubicin—uterine cancer	0.000242	0.000643	CcSEcCtD
Mirabegron—ABCB1—decidua—uterine cancer	0.000239	0.0177	CbGeAlD
Mirabegron—CYP2D6—female gonad—uterine cancer	0.000238	0.0176	CbGeAlD
Mirabegron—Rash—Doxorubicin—uterine cancer	0.000238	0.000631	CcSEcCtD
Mirabegron—Dermatitis—Doxorubicin—uterine cancer	0.000237	0.000631	CcSEcCtD
Mirabegron—Headache—Doxorubicin—uterine cancer	0.000236	0.000627	CcSEcCtD
Mirabegron—ABCB1—renal system—uterine cancer	0.000235	0.0174	CbGeAlD
Mirabegron—BCHE—lymph node—uterine cancer	0.000231	0.0171	CbGeAlD
Mirabegron—ABCB1—endometrium—uterine cancer	0.000227	0.0168	CbGeAlD
Mirabegron—Nausea—Doxorubicin—uterine cancer	0.000224	0.000595	CcSEcCtD
Mirabegron—ABCB1—mammalian vulva—uterine cancer	0.00022	0.0162	CbGeAlD
Mirabegron—ABCB1—uterus—uterine cancer	0.000209	0.0155	CbGeAlD
Mirabegron—ABCB1—female reproductive system—uterine cancer	0.000188	0.0139	CbGeAlD
Mirabegron—ABCB1—female gonad—uterine cancer	0.000171	0.0127	CbGeAlD
Mirabegron—ABCB1—vagina—uterine cancer	0.00017	0.0126	CbGeAlD
Mirabegron—ABCB1—lymph node—uterine cancer	0.00011	0.00814	CbGeAlD
